reviewJournal of Diabetes InvestigationFeb 1, 2010BRONZE OA

GIP and GLP‐1, the two incretin hormones: Similarities and differences

Kansai Electric Power Hospital · Okayama Prefectural University

PubMed
Indexed incrossrefdoajpubmed

Abstract

Gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are the two primary incretin hormones secreted from the intestine on ingestion of glucose or nutrients to stimulate insulin secretion from pancreatic β cells. GIP and GLP-1 exert their effects by binding to their specific receptors, the GIP receptor (GIPR) and the GLP-1 receptor (GLP-1R), which belong to the G-protein coupled receptor family. Receptor binding activates and increases the level of intracellular cyclic adenosine monophosphate in pancreatic β cells, thereby stimulating insulin secretion glucose-dependently. In addition to their insulinotropic effects, GIP and GLP-1 play critical roles in various biological processes in…

Citation impact

708
total citations
FWCI
11.05
Percentile
100%
References
186
Citations per year

Authors

3

Topics & keywords

Keywords
  • Incretin
  • Gastric inhibitory polypeptide
  • Internal medicine
  • Endocrinology
  • Glucagon-like peptide-1
  • Hormone
  • Medicine
  • Receptor
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.